ImmuPharma (LON:IMM) Trading Up 4.9% – Should You Buy?

ImmuPharma plc (LON:IMM) shares were up 4.9% during trading on Saturday . The stock traded as high as GBX 4.70 ($0.06) and last traded at GBX 3.67 ($0.04). Approximately 109,382,164 shares were traded during trading, an increase of 245% from the average daily volume of 31,664,631 shares. The stock had previously closed at GBX 3.50 ($0.04).

ImmuPharma Stock Performance

The stock’s fifty day moving average is GBX 1.40 and its 200 day moving average is GBX 1.65. The stock has a market cap of £15.30 million, a P/E ratio of -367.30 and a beta of 1.53.

ImmuPharma Company Profile

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.